Ascidian Therapeutics
Ascidian Therapeutics is redefining the treatment of disease by rewriting RNA. By editing exons at the RNA level, Ascidian therapies enable precise post-transcriptional editing of genes, resulting in full-length, functional proteins at the right levels, in the right cells, at the right time. With active discovery and preclinical programs in ophthalmology, neurological and neuromuscular disorders, and other rare diseases, Ascidian is opening new therapeutic possibilities for patients in need of breakthroughs.
Domain
ascidian-tx.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$40.0M
Founded
2019
Tech Stack (18 technologies)
Frequently Asked Questions
What technologies does Ascidian Therapeutics use?+
Ascidian Therapeutics uses 18 technologies including Google Analytics, Google Tag Manager, WordPress.
What industry is Ascidian Therapeutics in?+
Ascidian Therapeutics operates in the Biotechnology industry.
Where is Ascidian Therapeutics based?+
Ascidian Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026